Research uncovers new potential target for ovarian cancer therapies

Covid-19: 237m vaccine doses to be distributed worldwide over next three months
4 March 2021
Two gaps to fill for the 2021-2022 winter wave of COVID-19 cases
4 March 2021

Research uncovers new potential target for ovarian cancer therapies

Promoting gamma delta T cell response could be an effective strategy for treating advanced ovarian cancer, according to research by an international team from Karolinska Institutet, Menoufia University in Egypt, and the Royal Institute of Technology in Sweden. Their work has been published in Science Translational Medicine.

Comments are closed.